產(chǎn)品描述: | MCC950 (CP-456773, CRID3) 是一種有效的 NLRP3 (NOD-like receptor (NLR) family, pyrin domain-containing protein 3) 的選擇性抑制劑,在BMDMs和HMDMs中對應(yīng)的IC50值分別為7.5 nM和8.1 nM |
靶點(diǎn): |
NLRP3(BMDM-based assay):7.5 nM; NLRP3(HMDM-based assay):8.1 nM;NOD |
體外研究: |
MCC950 specifically inhibits NLPR3 inflammasome activation |
體內(nèi)研究: |
Inhibition of NLRP3 with MCC950 ameliorates proteinuria, renal histological lesions and podocyte foot process effacement in lupus-prone mice |
細(xì)胞實(shí)驗(yàn): |
Cell lines: NZM2328 podocyte cell line Concentrations: 1 μM Incubation Time: 24 h Method: The NZM2328 podocyte cell line was stimulated with a control serum or a serum from diseased NZM2328 mice or serum from diseased NZM2328 mice depleted of IgG, with or without MCC950 or Mito TEMPO for 24 hours. After this incubation, cells were subjected to flow cytometry and Western blot analyses for NLRP3 inflammasome activation, mitochondrial membrane potential and production of reactive oxygen species (ROS) analysis. |
動物實(shí)驗(yàn): |
Animal Models: female NZM2328, a new NZM strain produced by extended backcrosses of NZB/WF1 to NZW mice Dosages: 10mg/kg Administration: i.p. |
參考文獻(xiàn): |
1. Fu R, et al. Podocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis. Arthritis Rheumatol. 2017 Aug;69(8):1636-1646. 2. Joshi H, et al. L-plastin enhances NLRP3 inflammasome assembly and bleomycin-induced lung fibrosis. Cell Rep. 2022 Mar 15;38(11):110507. 3. Xie H, et al. Effects of mitochondrial reactive oxygen species-induced NLRP3 inflammasome activation on trichloroethylene-mediated kidney immune injury. Ecotoxicol Environ Saf. 2022 Oct 1;244:114067. |
溶解性: |
Soluble in DMSO、Ethanol |
保存條件: |
-20℃ |
配置溶液濃度參考: |
|
1mg |
5mg |
10mg |
1 mM |
2.472 ml |
12.362 ml |
24.723 ml |
5 mM |
0.494 ml |
2.472 ml |
4.945 ml |
10 mM |
0.247 ml |
1.236 ml |
2.472 ml |
50 mM |
0.049 ml |
0.247 ml |
0.494 ml |
|
注意: |
部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。 |